On the underreporting of health-related quality of life and regulatory approval

D. Bhamidipati; S. Anand; A. Gothwal; K. Raghav; M. J. Overman

doi:10.1093/annonc/mdz033

On the underreporting of health-related quality of life and regulatory approval

D. Bhamidipati, S. Anand, A. Gothwal, K. Raghav, M. J. Overman

GI Medical Oncology

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English (US)
Article number	mdz033
Pages (from-to)	657-658
Number of pages	2
Journal	Annals of Oncology
Volume	30
Issue number	4
DOIs	https://doi.org/10.1093/annonc/mdz033
State	Published - Apr 2019

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdz033

Cite this

@article{9061b0f355834e6da93cf2a733345d8d,

title = "On the underreporting of health-related quality of life and regulatory approval",

author = "D. Bhamidipati and S. Anand and A. Gothwal and K. Raghav and Overman, {M. J.}",

note = "Funding Information: This work was supported by a research grant from Bristol-Myers Squibb to the Department of Medical Oncology and by a grant of the Medical Faculty of the University Duisburg-Essen (IFORES fellowship to MW). The West German Cancer Center receives grant support from the Oncology Center of Excellence Program of the Deutsche Krebshilfe (110534); and as partner site of the German Cancer Consortium (DKTK) by the German Federal and State governments. The funding sources had no influence on the analysis and interpretation of data.",

year = "2019",

month = apr,

doi = "10.1093/annonc/mdz033",

language = "English (US)",

volume = "30",

pages = "657--658",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "4",

}

TY - JOUR

T1 - On the underreporting of health-related quality of life and regulatory approval

AU - Bhamidipati, D.

AU - Anand, S.

AU - Gothwal, A.

AU - Raghav, K.

AU - Overman, M. J.

N1 - Funding Information: This work was supported by a research grant from Bristol-Myers Squibb to the Department of Medical Oncology and by a grant of the Medical Faculty of the University Duisburg-Essen (IFORES fellowship to MW). The West German Cancer Center receives grant support from the Oncology Center of Excellence Program of the Deutsche Krebshilfe (110534); and as partner site of the German Cancer Consortium (DKTK) by the German Federal and State governments. The funding sources had no influence on the analysis and interpretation of data.

PY - 2019/4

Y1 - 2019/4

UR - http://www.scopus.com/inward/record.url?scp=85066880630&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066880630&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdz033

DO - 10.1093/annonc/mdz033

M3 - Letter

C2 - 30698646

AN - SCOPUS:85066880630

SN - 0923-7534

VL - 30

SP - 657

EP - 658

JO - Annals of Oncology

JF - Annals of Oncology

IS - 4

M1 - mdz033

ER -

On the underreporting of health-related quality of life and regulatory approval

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this